:::
勞保資訊 yang - 勞健保資訊 | 2025-06-13 | 點閱數： 352

報稅期間如何查調勞（就、災）保、農（職）保、國保個人繳費證明？

發布日期：2025-04-01

勞動部勞工保險局（下稱本局）已將113年度勞（就、災）保、農（職）保、國保個人繳（計）費資料提供給財政部，請被保險人多加利用網路申報綜合所得稅，申報系統上會自動顯示該年度「人身保險（非健保）費可扣除總金額」（含勞（就、災）保、農（職）保、國保），不需另行查調；若非網路報稅，可依下列方式查調各項保險費繳費證明。

壹、勞（就、災）保：

一、列舉申報綜合所得稅時，被保險人如何取得勞（就、災）保保險費繳（計）費證明？

答：

  1. 網路列印：114年4月1日起至115年3月31日止，被保險人可利用「自然人憑證」、「虛擬勞保憑證」、「行動自然人憑證」、「金融電子憑證」或「行動電話認證（月租型）」登入本局e化服務系統-個人，線上列印113年度勞（就、災）保保險費繳（計）費年度證明。
    • 查詢路徑：本局全球資訊網＞線上申辦＞e化服務系統（需登入）＞ 個人申報及查詢＞個人＞繳款單/繳費證明>繳費證明＞勞（就、災）保保險費繳（計）費年度證明
  2. 向投保單位申請：被保險人應自行負擔之保險費，應由投保單位於扣、收繳後註明於薪資單（袋）上或掣發收據予被保險人。爰被保險人個人保險費繳費證明或收據係向投保單位索取。
  3. 臨櫃申請：114年4月1日起至同年6月30日止，可持附有照片之身分證明文件及印章親自或委託他人（須出示委託書）向本局各地辦事處查詢列印保險費繳（計）費證明。

二、投保單位如何取得員工113年度保險費自負額已繳納資料？

答：依投保單位是否為本局網路申辦單位區分，取得方式有下列二種：

  1. 網路申辦單位：114年4月1日起至同年6月30日止，利用已授權之經辦人之「自然人憑證」、「虛擬勞保憑證」、「行動自然人憑證」、「金融電子憑證」登入本局e化服務系統－投保單位，即可下載「被保險人年度已繳保險費自負額資料」，以便開立保險費繳費證明給被保險人報稅使用。
    • 查詢路徑：本局全球資訊網＞線上申辦＞e化服務系統（需登入）＞ 投保單位申報及查詢＞投保單位網路申報及查詢作業＞資料查詢作業＞被保險人年度已繳保險費自負額資料查詢
    • 如依據查詢路徑查無此作業，請利用單位憑證及授權管理者之自然人憑證，至本局e化服務系統＞投保單位：憑證註冊與指派作業＞指派作業，執行授權指派作業並存檔。
  2. 非網路申辦單位：請先向本局申請「投保單位被保險人名冊」，再自行核算開立保險費繳費證明給被保險人。申請「投保單位被保險人名冊」應填具「投保單位被保險人名冊申請書」（不具格式），寫明單位名稱、保險證號、負責人、承辦人姓名、聯絡電話、通訊地址、用途及申請月份，蓋上投保單位及負責人印章，將該申請書郵寄至「勞動部勞工保險局保費組保險年資科」或傳真至02-2395-8551。如有疑義，可電洽本局保費組保險年資科（02-2396-1266轉分機1977）詢問。

貳、農（職）保：

一、列舉申報綜合所得稅時，被保險人如何取得農（職）保保險費繳（計）費證明？

答：

  1. 網路列印：114年4月1日起至同年6月30日止，被保險人可利用「自然人憑證」、「虛擬勞保憑證」、「行動自然人憑證」、「金融電子憑證」或「行動電話認證（月租型）」登入本局e化服務系統-個人，線上列印農（職）保保險費繳（計）費證明。
    • 查詢路徑：本局全球資訊網＞線上申辦＞e化服務系統（需登入）＞個人申報及查詢＞個人＞繳款單/繳費證明＞繳費證明＞農（職）保保險費繳（計）費證明）
  2. 向投保農會申請。
  3. 臨櫃申請：114年4月1日起至同年6月30日止，可持附有照片之身分證明文件及印章親自或委託他人（須出示委託書）向本局各地辦事處查詢列印農（職）保保險費繳（計）費證明。

參、國保：

一、列舉申報綜合所得稅時，被保險人如何取得國民年金繳費證明？

答：

  1. 網路列印：114年2月1日起至同年12月31日止，可使用「自然人憑證」、「虛擬勞保憑證」、「行動自然人憑證」、「金融電子憑證」或「行動電話認證（月租型）」登入本局e化服務系統-個人，線上列印國民年金繳費證明。
    • 查詢路徑：本局全球資訊網＞線上申辦＞e化服務系統（需登入）＞個人申報及查詢＞個人＞繳款單/繳費證明＞繳費證明＞國民年金繳費證明
  2. 網路申請郵寄：114年2月1日起至同年12月31日止，可至本局全球資訊網＞線上申辦＞國民年金保險費補單及繳費證明申請＞國民年金繳費證明申請郵寄＞國民年金繳費證明郵寄申請作業，輸入身分證號及出生日期，即可線上申請郵寄國民年金繳費證明。
  3. 臨櫃申請：114年2月1日起至同年12月31日止，可持附有照片之身分證明文件及印章親自或委託他人（須出示委託書）向本局各地辦事處查詢列印國民年金繳費證明。
  4. 電話申請：114年2月1日起至同年12月31日止，可電洽本局國民年金組（02-2396-1266轉分機6033）申請國民年金繳費證明。

以上資料來源:勞保局

 

網友個人意見，不代表本站立場，對於發言內容，由發表者自負責任。
發表者
樹狀展開
 

 What's New About Ipamorelin For Women Side Effects

The long‑term use of ipamorelin, particularly in the form known as CJC Ipamorelin, has raised questions among users and healthcare professionals alike about potential side effects that may arise over months or years of therapy. While short‑term trials have generally reported a favorable safety profile, extended exposure can lead to subtle physiological changes that warrant careful monitoring. Understanding these risks is essential for anyone considering chronic use, whether for bodybuilding, anti‑aging, or medical purposes such as growth hormone deficiency treatment. CJC Ipamorelin Side Effects: What You Need to Know The most commonly cited short‑term side effects of ipamorelin include mild injection site reactions, transient headaches, and occasional nausea. However, when used over a longer period, additional concerns have emerged. One of the primary issues is the potential for elevated growth hormone levels to affect insulin sensitivity. Chronic exposure may lead to changes in glucose metabolism that could predispose individuals to insulin resistance or type 2 diabetes. Another area of concern involves the endocrine system’s feedback loops; sustained stimulation of growth hormone release can alter the regulation of other pituitary hormones such as prolactin and thyroid‑stimulating hormone, potentially causing imbalances. Patients who have reported long‑term effects also mention increased water retention, which may manifest as mild edema in the extremities or face. This fluid shift is believed to be linked to growth hormone’s influence on vasopressin secretion and renal handling of sodium. In addition, some users describe an enhanced tendency toward fatigue or a feeling of heaviness during prolonged activity, possibly due to altered energy metabolism. Another subtle but noteworthy long‑term effect involves the cardiovascular system. Growth hormone has trophic effects on cardiac tissue, and prolonged high levels could contribute to changes in heart structure or function over time. While definitive clinical evidence is still limited, animal studies suggest that chronic growth hormone excess can lead to myocardial hypertrophy, which may increase the risk of arrhythmias or reduced cardiac efficiency. What is CJC Ipamorelin? CJC Ipamorelin is a synthetic peptide belonging to the ghrelin‑like class of growth hormone secretagogues. It was first developed by researchers at the University of Kansas and later refined by pharmaceutical companies seeking a selective, potent stimulator of growth hormone release. The peptide’s design allows it to bind with high affinity to the growth hormone secretagogue receptor while sparing other receptors that could trigger unwanted side effects such as increased cortisol or prolactin. Unlike some older secretagogues, CJC Ipamorelin has a minimal impact on appetite and does not typically stimulate significant food intake. This feature makes it attractive for users who want to increase lean muscle mass without gaining excess body fat. In clinical settings, it is sometimes prescribed for growth hormone deficiency or as part of anti‑aging protocols aimed at improving tissue repair and metabolic health. The peptide’s pharmacokinetics are relatively straightforward; after subcutaneous injection it reaches peak plasma concentration within 30 minutes and has a half‑life of roughly one hour. Because of its short duration, users often administer multiple doses per day to maintain steady growth hormone levels. The safety profile in acute studies is reassuring, but the long‑term picture remains less clear. Feeling Light‑headed or Weak One of the more frequently reported subjective experiences among long‑term ipamorelin users is a sensation of lightness or weakness that occurs intermittently, especially after dosing. This feeling can range from mild dizziness to a pronounced sense of fatigue. The underlying mechanism is not fully understood but may involve transient changes in blood pressure or neurohumoral regulation. Growth hormone has vasoactive properties; it can dilate blood vessels and alter peripheral resistance. In the context of repeated peptide administration, these vascular effects could cause brief episodes of lowered blood pressure, which would manifest as light‑headedness. Additionally, ipamorelin’s action on the hypothalamic‑pituitary axis may influence catecholamine levels, further contributing to fluctuations in energy and alertness. Another potential contributor is the redistribution of fluid within the body. As growth hormone promotes sodium retention and increases plasma volume, some individuals experience a feeling of heaviness or sluggishness when their circulatory system is adjusting to these changes. Over time, this may manifest as intermittent weakness, especially during periods of intense training or prolonged standing. Monitoring for light‑headedness or weakness should involve keeping a log of symptoms relative to dosing times and activity levels. If the episodes become frequent or severe, it may be advisable to adjust the dosage schedule, reduce frequency, or consult a medical professional for evaluation of blood pressure and endocrine function.

 

 The Number One Question You Must Ask For Split

Anavar, also known as oxandrolone, has become a popular choice among athletes and bodybuilders looking for lean muscle gains and enhanced recovery while minimizing the risk of severe side effects typically associated with other anabolic steroids. Understanding how to structure an Anavar cycle alongside testosterone can help users achieve optimal results in terms of strength, definition, and overall performance, especially when following guidelines that have evolved into 2025 best practices. --- Anavar Cycle Guide: Safe Dosage & Best Results 2025 1. The Foundation – Why Combine Anavar with Testosterone? Synergy: Testosterone is a natural anabolic hormone that promotes muscle growth, fat loss, and recovery. When paired with Anavar, the combination can increase protein synthesis without dramatically increasing water retention or androgenic side effects. Reduced Risk of Estrogenic Effects: Anavar itself does not aromatize into estrogen; however, testosterone can. Using a balanced dosage helps avoid gynecomastia or edema while still maintaining hormonal support. 2. Standard Cycle Length and Stacking Typical Duration: A standard cycle for beginners is 6–8 weeks, while experienced users might extend to 10–12 weeks for more pronounced gains. Stacking Order: - Week 1–2: Initiate testosterone (often 200–250 mg per week) and Anavar at a low dose of 20–30 mg per day. - Weeks 3–6: Increase Anavar to 40–50 mg per day if tolerated, while maintaining testosterone at the same level. - Optional Week 7–8: Add an aromatase inhibitor (e.g., anastrozole) if estrogen spikes are noted. 3. Dosage Guidelines Anavar: - Beginners: 20–30 mg daily - Intermediate/Advanced: 40–50 mg daily - Advanced or cutting cycles: up to 60 mg daily (with close monitoring) Testosterone: - Natural baseline users: 200–250 mg per week via intramuscular injection - Those with low endogenous levels may require higher dosages, but should consult a medical professional. 4. Timing & Administration Anavar is best taken in divided doses (e.g., morning and evening) to maintain steady blood levels. Testosterone injections are typically administered once per week; spacing out the dose on days when Anavar is at its peak can help avoid peaks that might trigger side effects. 5. Nutritional Support Protein Intake: Aim for 1.0–1.2 grams of protein per pound of body weight to support muscle repair. Carbohydrates & Fats: Maintain a moderate carbohydrate intake to fuel workouts and ensure essential fatty acids are available for hormone synthesis. Hydration: Stay well-hydrated, especially when using testosterone, as it can increase fluid retention. 6. Monitoring & Safety Blood Work: Schedule comprehensive blood panels before starting the cycle, mid-cycle (around week 4), and post-cycle to monitor liver function, lipid profile, and hormone levels. Side Effects to Watch For: - Liver strain (rare with Anavar but still possible) - Testosterone suppression or estrogenic symptoms - Mood swings or changes in libido - Cardiovascular stress 7. Post-Cycle Therapy (PCT) A typical PCT for this stack might involve an aromatase inhibitor followed by a selective estrogen receptor modulator such as tamoxifen. The duration of PCT generally lasts 4–6 weeks, ensuring that natural testosterone production resumes and estrogen levels return to baseline. What is Oxandrolone? Oxandrolone is the chemical name for Anavar, one of the most widely used oral anabolic steroids. It was first synthesized in the 1960s by Searle Laboratories as a derivative of dihydrotestosterone (DHT). The goal was to create an androgen that retained strong anabolic properties while reducing androgenic side effects such as hair loss or virilization. Key Characteristics Low Aromatization: Unlike many other steroids, oxandrolone does not convert into estrogen, which means it typically does not cause water retention or gynecomastia. Mild Androgenic Profile: It has a lower tendency to produce classic male secondary sexual characteristics, making it safer for use in both men and women when dosage is kept within recommended limits. Rapid Protein Synthesis: Oxandrolone increases the rate of protein synthesis in muscle cells, facilitating lean mass gains with minimal fat retention. Medical Applications Beyond bodybuilding, oxandrolone has legitimate therapeutic uses. It can be prescribed for: Weight loss after severe illness or injury Enhancing recovery from bone fractures Managing chronic wasting conditions Its prescription status ensures that it is available only through a licensed healthcare provider, and misuse can lead to legal penalties. Common Forms The drug is typically supplied as oral tablets (10 mg, 20 mg) which makes it convenient for those who prefer not to inject. Because of its oral nature, liver toxicity risk is higher than injectable steroids; however, oxandrolone is considered relatively mild compared to older oral compounds like methandrostenolone. --- Sign Up for Newsletter If you want to stay updated on the latest research, dosage protocols, and cutting-edge cycle designs tailored to 2025 standards, consider subscribing to a trusted bodybuilding or medical newsletter. These newsletters often include: Expert articles on new synthetic steroids Weekly dosage calculators Personal anecdotes from seasoned users Alerts about legal changes affecting steroid availability When signing up, verify that the newsletter comes from reputable sources such as well‑known sports medicine journals, professional bodybuilding associations, or established supplement companies with transparent testing protocols. This will help you receive reliable information and avoid misinformation that could compromise your health or performance goals.